Evidence for a gamma-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of Met5-enkephalin elicited by depolarization.
D000818:Animals; D001569:Benzodiazepines / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism; D004723:Endorphins / Q000378:metabolism*; D004744:Enkephalin, Methionine; D004745:Enkephalins / Q000378:metabolism*; D005971:Glutamates / Q000378:metabolism; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009118:Muscimol / Q000494:pharmacology; D015260:Neprilysin; D011189:Potassium Chloride / Q000494:pharmacology; D011480:Protease Inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D013570:Synaptic Membranes / Q000187:drug effects / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D004723:Endorphins; D004745:Enkephalins; D005971:Glutamates; D011480:Protease Inhibitors; D001569:Benzodiazepines; D009118:Muscimol; D005680:gamma-Aminobutyric Acid; D004744:Enkephalin, Methionine; D011189:Potassium Chloride; D015260:Neprilysin; D007538:Isoniazid